Subtype
Skin Basal Cell Carcinoma
CI-CAN-00003940BCCExplore in graph →
17 active trials1 approved drugs
Loading cancer entity…
Subtype
CI-CAN-00003940BCCExplore in graph →
Clinical trials
83 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (4)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06271603 | Evaluation of the Efficiency and Economic Impact of LC-OCT (Line-field Confocal Optical Coherence Tomography) for the Diagnosis and Management of Basal Cell Carcinomas(ECOBASO) | unknown | N/A | 704 | Damae MedicalINDUSTRY | 1 | Feb 22, 2024 | clinicaltrials |
| NCT06150144 | The Efficacy and Safety of Using Intralesional 5-fluorouracil for Basal Cell Carcinoma | unknown | Phase 3 | 40 | University of AleppoOTHER | 1 | Jan 2, 2024 |
| clinicaltrials |
| NCT02242929 | Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma(SCIN) | unknown | Phase 3 | 145 | Maastricht University Medical CenterOTHER | 1 | Sep 24, 2021 | clinicaltrials |
| NCT03621462 | Elucid Labs AIDA™ - Labelled Image Acquisition Protocol | unknown | N/A | 4,000 | Elucid Labs Inc.INDUSTRY | 1 | Aug 8, 2018 | clinicaltrials |
| NCT01491711 | Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate | unknown | Phase 4 | 162 | Maastricht University Medical CenterOTHER | 1 | Jan 31, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Feb 22, 2024source: clinicaltrials